These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3819698)

  • 21. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    Payne LG
    J Gen Virol; 1980 Sep; 50(1):89-100. PubMed ID: 7441216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins, their inhibitors and cancer.
    Lupulescu A
    Prostaglandins Leukot Essent Fatty Acids; 1996 Feb; 54(2):83-94. PubMed ID: 8848435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
    Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus.
    Santoro MG; Favalli C; Mastino A; Jaffe BM; Esteban M; Garaci E
    Arch Virol; 1988; 99(1-2):89-100. PubMed ID: 3355375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Langerhans cells in vaccinia virus infection in mouse skin.
    Becker Y; Sprecher E
    Arch Virol; 1989; 107(3-4):307-13. PubMed ID: 2818209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production.
    Bamba H; Ota S; Kato A; Matsuzaki F
    Biochem Biophys Res Commun; 1998 Apr; 245(2):567-71. PubMed ID: 9571196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the pathogenicity and immunogenicity of vaccinia virus to piglets.
    Imada T; Kawamura H; Nishimori T; Murata H; Narita M; Honda Y; Ishigaki K
    Nihon Juigaku Zasshi; 1989 Feb; 51(1):96-104. PubMed ID: 2927042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of a correlation between humoral and cellular responses to a vaccinia virus and products of the major histocompatibility complex in rhesus monkeys.
    Stitz L; Kreeftenberg JG; Loggen HG; Balner H
    Antiviral Res; 1981 Sep; 1(3):193-9. PubMed ID: 7337432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of mice against vaccinia virus by bacterial infection and sustained stimulation with specific bacterial antigens.
    Allen EG; Mudd S
    Infect Immun; 1973 Jan; 7(1):62-7. PubMed ID: 4632135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinia virus infection of the central nervous system in X-irradiated mice.
    Simon J; Werner GT
    Infect Immun; 1979 Sep; 25(3):1035-42. PubMed ID: 500184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of macrophages in the pathogenicity of vaccinia virus for young rats].
    Dabrowski W; Andrzejewski J; Bogunowicz A
    Med Microbiol Immunol; 1972; 158(2):113-20. PubMed ID: 4641939
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of polyriboinosinic-polyribocytidylic acid and antibody on infection of immunosuppressed mice with vaccinia virus.
    Worthington M; Baron S
    J Infect Dis; 1973 Sep; 128(3):308-11. PubMed ID: 4728690
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody to vaccinia. II. Prevalence in blood donors.
    Entwistle CC
    Vox Sang; 1975; 28(1):77-80. PubMed ID: 1114789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccinia virus meningitis in mice after intracerebral inoculation.
    Ginsberg AH; Johnson KP
    Infect Immun; 1976 Apr; 13(4):1221-7. PubMed ID: 179952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of triterpenic compounds with prostaglandin A1 on vaccinia virus infected L929 cells.
    Lampis G; Ingianni A; Pompei R
    Antiviral Res; 1997 Dec; 36(3):191-5. PubMed ID: 9477119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Cell-mediated defence against virus infections in mice.
    Plantinga AD; de Jong JC; Harmsen M; Straaten-Hekerman MP; Khader Boutahar-Trouw BJ
    Antonie Van Leeuwenhoek; 1975; 41(2):216. PubMed ID: 1080401
    [No Abstract]   [Full Text] [Related]  

  • 39. Respiratory infection of mice with vaccinia virus.
    Turner GS
    J Gen Virol; 1967 Jul; 1(3):399-402. PubMed ID: 6082340
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal relationship of interferon production and resistance to experimentally induced virus infection.
    Ash RJ; Bubel HC
    J Infect Dis; 1966 Feb; 116(1):1-7. PubMed ID: 5908851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.